Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

By Nishimura Reiki  

Breast Cancer, Vol. 17, Iss. 4, 2010-10 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite

Immunophenotype of Ovarian Cancer as Predictor of Clinical Outcome: Evaluation at Primary Surgery and Second-Look Procedure

By Goff B.A.   Ries J.A.   Els L.P.   Coltrera M.D.   Gown A.M.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 378-385

Elsevier

Access to resources Recommend Favorite

Impact of Obesity on Operative Morbidity and Clinical Outcome in Primary Epithelial Ovarian Cancer after Optimal Primary Tumor Debulking

By Fotopoulou Christina   Richter Rolf   Braicu Elena-Ioana   Kuhberg Marc   Feldheiser Aarne   Schefold Joerg   Lichtenegger Werner   Sehouli Jalid  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2629-2637

Springer Publishing Company

Access to resources Recommend Favorite

The value of serum bcl-2 levels in advanced epithelial ovarian cancer

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 213-217

Humana Press, Inc

Access to resources Recommend Favorite

Activated Matrix Metalloproteinase-2-A Potential Marker of Prognosis for Epithelial Ovarian Cancer

By Wu X.   Li H.   Kang L.   Li L.   Wang W.   Shan B.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 126-134

Elsevier

Access to resources Recommend Favorite